Aνταλένα Τσατσοπούλου ΝΙΚΟΣ ΠΡΩΤΟΝΟΤΑΡΙΟΣ ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ - ΝΑΞΟΣ. Arrhythmogenic Cardiomyopathy

Similar documents
Update on use of cardiac MRI in ARVC/D. Stefan L. Zimmerman, MD Johns Hopkins University Department of Radiology

Arrhythmogenic Cardiomyopathy cases. Δέσποινα Παρχαρίδου Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογική κλινική ΑΧΕΠΑ

Implications of the new diagnostic criteria for ARVC

Prevention of Sudden Death in ARVC

INTRODUCTION. left ventricular non-compaction is a sporadic or familial cardiomyopathy characterized by

BMR Medicine. Case Study YOUNG PATIENT WITH RECURRENT PRESYNCOPE: A CASE REPORT

Clinical aspects of Arrhythmogenic Cardiomyopathies

Unusual Serial Electrocardiographic Changes which Progressed to Arrhythmogenic Right Ventricular Cardiomyopathy

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

Name of Presenter: Marwan Refaat, MD

FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol

Benign RVOT Ectopy and RV dysplasia

Heart Rhythm Disorders. How do you quantify risk?

DELAYED ENHANCEMENT IMAGING IN CHILDREN

27-year-old professionnal rugby player: asymptomatic

DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY. David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong

Arrhythmogenic Right Ventricular Cardiomyopathy. Europace June 28,2011

Sudden cardiac death: Primary and secondary prevention

ARVC when TO IMPLANT THE ASYMPTOMATIC PERSON

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS

Risk Factors for Sudden cardiac Death

Left ventricular non-compaction: the New Cardiomyopathy on the Block

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Arrhythmias (II) Ventricular Arrhythmias. Disclosures

Clinical phenotypes associated with Desmosome gene mutations

Keywords: Arrhythmogenic right ventricular dysplasia/cardiomyopathy; Naxos disease; Cell adhesions;

HYPERTROPHIC CARDIOMYOPATHY RISK STRATIFICATION WHAT IS NEW?

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine

Biventricular Arrhythmogenic Cardiomyopathy: A New Paradigm?

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

CONGENITAL CORONARY ARTERY ANOMALIES

ECG Workshop. Nezar Amir

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Congestive Heart Failure or Heart Failure

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Ablative Therapy for Ventricular Tachycardia

Case based learning: CMR in Heart Failure

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

at least 4 8 hours per week

Use of Biventricular Pacing in Arrhythmogenic Right Ventricular Cardiomyopathy with Disarticulated Right Ventricle

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

La valutazione dell atleta: è una strategia salva-vita e costo-efficace?

6/19/2018. Background Athlete s heart. Ultimate question. Applying the International Criteria for ECG

Cardiac MRI: Clinical Application to Disease

What s New in Cardiac MRI

Tachycardias II. Štěpán Havránek

Investigating the family after a sudden cardiac death. Dr Catherine Mercer Consultant Clinical Geneticist, Wessex

Jonathan Kim MD, FACC

EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES

Advances in Ablation Therapy for Ventricular Tachycardia

What s new in Hypertrophic Cardiomyopathy?

An Approach to the Patient with Syncope. Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva

Cardiac MRI: Cardiomyopathy

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Analysis based on six cases

EKG screening in athletics

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest

Left-Dominant Arrhythmogenic Cardiomyopathy

Isolated Cardiac Sarcoidosis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy

Update in Cardiomyopathies: Their New Classifications and Importance of Mixed Phenotypes

Cardiac MRI: Clinical Application to Disease

Impact of the Revision of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Task Force Criteria on Its Prevalence by CMR Criteria

Paroxysmal Supraventricular Tachycardia PSVT.

THE ROLE OF MOLECULAR AUTOPSY IN 2014: FROM THE ANATOMICAL THEATRE TO THE DOUBLE HELIX. Gaetano Thiene, MD

The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.s358l mutation in TMEM43

Apical Hypertrophic Cardiomyopathy With Hemodynamically Unstable Ventricular Arrhythmia Atypical Presentation

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Arrhythmogenic right ventricular cardiomyopathy/dysplasia

How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto

Mitral Valve Disease, When to Intervene

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια:

Sudden Death (SD) and hypertrophic cardiomyopathy (HCM) Attempt of risk stratification

Non-Cardiac Sudden Death in a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy

Interpretation and Consequences of Repolarisation Changes in Athletes

Cardiomyopathy in Fabry s disease

Current Indications for Cardiac MRI: What You See is What You Get?

Cardiomyopathy. ACOI IM Board Review 2018 Martin C. Burke DO, FACOI

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

Antony French Consultant Cardiologist & Electrophysiologist

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen

SABIHA GATI AND SANJAY SHARMA

The Heart Is A Muscle Too! The Cardiomyopathy In Duchenne Muscular Dystrophy

CARDIOMYOPATHY IN CT. Hans- Christoph Becker Professor of Radiology

Study methodology for screening candidates to athletes risk

Newly Diagnosed Heart Failure patient: When to Order an MRI and Why

Arrhythmias on the AMU

NEW GUIDELINES MAJOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC MINOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC

3/17/2014. WS # 3 ICD Registry Case Scenarios with Structural Abnormalities. Objectives. Denise Pond BSN, RN

Clinical Genetics in Cardiomyopathies

SUDDEN CARDIAC DEATH(SCD): Definition

Role of CMR in heart failure and cardiomyopathy

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole

VENTRICULAR TACHYCARDIA IN THE ABSENCE OF STRUCTURAL HEART DISEASE

Transcription:

Aνταλένα Τσατσοπούλου ΝΙΚΟΣ ΠΡΩΤΟΝΟΤΑΡΙΟΣ ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ - ΝΑΞΟΣ Arrhythmogenic Cardiomyopathy

Aνταλένα Τσατσοπούλου ΝΙΚΟΣ ΠΡΩΤΟΝΟΤΑΡΙΟΣ ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ - ΝΑΞΟΣ There is no conflict of interest

Arrhythmogenic Cardiomyopathy Phenotype

Arrhythmogenic Cardiomyopathy Phenotype Recognise the Spectrum

Arrhythmogenic Cardiomyopathy Phenotype VT

Arrhythmogenic Cardiomyopathy Phenotype Re-entry VT

ECG Repolarization Depolarization Abnormalities V1 V2 V3 Re-entry VT

ECG Repolarization Depolarization Abnormalities V1 V2 V3 IMAGING RV Functional / Structural Alterations

1980-1990

1980-1990 PHENOTYPES Juvenile sudden deaths HCM Uhl s Normal coronaries

TFC 1994 ARVD / C

I ARVC - TFC Diagnostic Criteria 2004-2010 ARRHYTHMIAS II III IV V VI REPOLARIZATION ABNORMALITIES DEPOLARIZATION ABNORMALITIES STRUCTURAL / WALL MOTION STRUCTURAL (TISSUE CHARACTER) FAMILY HISTORY / GENETICS Major or Minor - - - Definite ARVC: 2 Major or 1 Major + 2 minor or 4 minor Borderline ARVC: 1 Major + 1 minor or 3 minor Suspected ARVC: 1 Major or 2 minor Unlike ARVC: 0 or 1 minor -

Dominant Recessive

Dominant Recessive

PHENOTYPE ~ CLINICAL PICTURE ECG, Str/Funct Birth Adolescence Age

SKIN MYOCARDIUM

SKIN Affected cell-cell contacts (desmosomes) MYOCARDIUM Plakoglobin McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, McKenna WJ. Lancet 2000

RV + LV Family studies

RV + LV JACC 2001 Pinamonti B, Sinagra G, Salvi A, et al. Left ventricular involvement in right ventricular dysplasia. Am Heart J 1992;123:711 24. Norman M, Simpson M, Mogensen J, et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation 2005;112:636. Bauce B, Basso C, Rampazzo A, et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 2005;26(16):1666-75. Sen-Chowdhry S, Syrris P, Prasad SK, et al. Left-dominant arrhythmo-genic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol 2008;52:2175. Available online at www.sciencedirect.com Journal of Electrocardiology xx (2013) xxx xxx www.jecgonline.com Quarta G, et al. ARVC and Lamin A/C gene mutations; Eur Heart J 2012 Kato K, Takahashi N, Fujii Y, et al. LMNA cardiomyopathy detected in Japanese arrhythmogenic right ventricular cardiomyopathy cohort. J Cardiol 2016;68(4):346-51. Left dominant arrhythmogenic cardiomyopathy: A morbid association of ventricular arrhythmias and unexplained infero-lateral T-wave inversion Alexandros Protonotarios, a, Alexandros Patrianakos, a Elpida Spanoudaki, b Georgios Kochiadakis, a Emmanouel Michalodimitrakis, b Panagiotis Vardas a a Department of Cardiology, University Hospital of Heraklion, Heraklion, Greece b Department of Forensic Sciences, University Hospital of Heraklion, Heraklion, Greece Ortiz-Genga MF, Cuenca S, Dal Ferro M, et al. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. J Am Coll Cardiol 2016;68 Abstract Left-dominant arrhythmogenic cardiomyopathy is a subtype of arrhythmogenic right ventricular cardiomyopathy characterized by early predominant left ventricular involvement. Α 34-year-old man presentedwithpalpitationsandahistory of frequent ventricular extrasystolesof bothlbbb andrbbb configuration. Cardiac workup revealed repolarization abnormalities at infero-lateral leads in the absence of diagnostic structural/functional alterations or obstructive coronary artery disease. Six months later he died suddenly. Histopathology was diagnostic for arrhythmogenic right ventricular cardiomyopathy affecting predominantly theleft ventricleat subepicardial/midwall myocardial layers. Thus, ventricular arrhythmias accompanied by unexplained infero-lateral T-wave inversion should warn of apossible morbid association underlying left-dominant arrhythmogenic cardiomyopathy. Begay RL, et al. Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell Cell Adhesion Structures. J Am Col Cardiol EP; 2018

Three main patterns of cardiac involvement are observed: 1. Predominant right ventricular disease, with minor or absent left ventricular involvement. 2. Biventricular disease, when both ventricles are affected. 3. Left dominant disease that is characterized by mild or absent right ventricular involvement. Terminology poorly defined Overlaps with dilated cardiomyopathy

Arrhythmogenic Dilated Cardiomyopathy (ADC) Recent registry study: Arrhythmogenic dilated cardiomyopathy (DCM) = DCM phenotype with 1 or more of the following: 1. Unexplained syncope (likely due to ventricular tachyarrhythmia). 2. Rapid non-sustained ventricular tachycardia defined as 5 consecutive ventricular beats lasting <30 seconds, with a rate 150/min on 24 hour Holter monitoring. 3. or 1000 premature ventricular contractions in, or 50 couplets, in 24 hours. 4. By these criteria, one third of DCM patients had an arrhythmogenic phenotype that was associated with an increased risk of arrhythmia during follow up. 5. A family history of ventricular arrhythmias predicted a poor prognosis and an increased risk of sudden cardiac death (SCD).

TFC Borderline phenotype minor disease TFC Borderline = borderline fitting to ARVC

Man, 43 year-old Asymptomatic

Man, 43 year-old Asymptomatic SD, 14 yrs Myocarditis

PRE-PARTICIPATION ECG?

Man, 43 year-old QRSf=126 ms LAS=78 ms RMS=11 μv 24-hour Holter: 324 monomorphic isolated VES TFC: 1 minor TFC: 1 minor

Man, 43 year-old, asymptomatic No diagnostic TFC structural / functional changes on ECHO - CMR CMR-Late Enhancement Imaging Extensive LV-LGE Scar in LV!

SD, previous day of admission for ICD implantation LV

Man, 43 year-old, asymptomatic SD 55y 60y DSP:Trp180Stop SD, 14 yrs DSP mutations mostly associated with Left- Dominant ARVC Diagnostic challenge Increased Risk for SD

Flow chart for ICD implantation Typical ARVC? Corrado D et al. Circulation 2015

Flow chart for ICD implantation Typical ARVC LV Scar Corrado D et al. Circulation 2015

Flow chart for ICD implantation Typical ARVC LV Scar Corrado D et al. Circulation 2015 DSP LMNA/C FLNC...

Man, 34 year-old

Man, 34 year-old Palpitations since 27-year-old No reports of syncope or pre-syncope No family history of cardiomyopathy or sudden death

Man, 34 year-old

Man, 34 year-old Low QRS voltage T-wave inversion in infero-lateral leads

RVOT=30 mm (<32 mm) LVEDD=59 mm (<58 mm) LVEF=60% Borderline cavity size Good function

LVEDD=59 mm LVEF=60% Regional hypokinesia of LV apex Mild regional wall motion abnormalities

Modified Apical View Mild hypokinesia of RV apex Mild regional wall motion abnormalities

Holter: VES >1000/24 h No VT 12-lead ECG: (Infero)lateral repolarization abnormalities ΕCHO: Mild/regional hypokinesia of LV/RV apex Exercise Test: Negative for myocardial ischemia No VT Coronary arteriography: No stenoses CMR-LE Metoprolol (50mgx2) and aspirin (100mgx1)

SD at rest Autopsy / Histopathology Eosin - Hematoxylin Masson Heart weight: 550 gr Fibrotic sub-epicardial / mid-wall bands in antero-lateral and postero-apical LV wall

K-Cr2707 Control N-Cadherin Plakoglobin Plakophilin2 Desmoplakin Connexin43 No desmosomal mutation

Ortiz-Genga, M.F. et al. J Am Coll Cardiol. 2016

FLNC Ortiz-Genga, M.F. et al. J Am Coll Cardiol. 2016

LV RV

DCM SD, 58 yrs Paroxysmal AF RV, LV progressive SD, 67 yrs Paroxysmal AF Bradycardia episodes No str/funct RV/LV Quarta G, et al. ARVC and Lamin A/C gene mutations; Eur Heart J 2012

50% loss of myocytes Control PG Immunostaining Quarta G, et al. ARVC and Lamin A/C gene mutations; Eur Heart J 2012

DCM SD, 58 yrs LMNA Paroxysmal AF RV, LV progressive SD, 67 yrs Paroxysmal AF Bradycardia episodes No str/funct RV/LV Quarta G, et al. ARVC and Lamin A/C gene mutations; Eur Heart J 2012

FLNC LMNA/C

Key points for Arrhythmogenic Cardiomyopathy A group of myocardial disorders with a high burden of ventricular arrhythmias AC is familial in about 60% of cases AC can affect one or both ventricles Three major sub-phenotypes: classical ARVC, left dominant ARVC, Arrhythmogenic DCM ECG abnormalities can precede overt structural manifestations. Exercise may promote disease progression and ventricular arrhythmia. Phenotype progresses during time: FU is important

Key points for Arrhythmogenic Cardiomyopathy Diagnostic criteria and management guidance exist for classical ARVC but further studies are required for other forms of AC

Key points for Arrhythmogenic Cardiomyopathy Symptomatic presentation of ventricular arrhythmias or a history of arrhythmic cardiac arrest in an otherwise normal myocardium should raise suspicion of an early AC phenotype.

TFC classical ARVC THE PHENOTYPES Early forms Left dominant ARVC Arrhythmogenic DCM Myocarditis Sarcoid The hidden phenotypes

Conditions affecting the Right Ventricle and Red Flags differentiating from ARVC Conditions affecting the RV and red flags differentiating from ARVC Cardiac displacement Pectus excavatum/ carinatum Kyphoscoliosis and/or another chest deformity Partial absence of pericardium RV pressure or volume overload Congenital heart defects - Ostium secundum - Sinus venosus - Ebstein s anomaly and/or tricuspid regurgitation Careful chest inspection for deformities and correlation of anatomy with CMR imaging To be excluded by TTE and/or CMR Absence of regional wall motion abnormalities Pulmonary Hypertension To be excluded by TTE and/or CMR. Absence of regional wall motion abnormalities Athlete s heart T-wave inversion extremely rare beyond V3 in whites. Myocardial Scarring Infectious myocarditis Absence of regional wall motion abnormalities. Symmetrical increase of wall thickness. Absence of LGE on CMR. Reversal upon deconditioning. Absence of familial disease Prodrome of an upper respiratory or GI tract infection Rapidly progressing ventricular dysfunction Sarcoidosis Inferior myocardial infarction Absence of familial disease 2 nd or 3 rd Degree atrioventricular block Extra-cardiac manifestations (pulmonary, mediastinum): chest x-ray, CT, PET, CMR-LGE. Evaluation of coronary artery anatomy A. Tsatsopoulou, E. Bossone, Common presentation of rare diseases: Arrhythmogenic right ventricular cardiomyopathy and its mimics, Int J Cardiol (2018), (In Press)

Not always as it seems to be